MSANTE : revenue, balance sheet and financial ratios

MSANTE is a French company founded 12 years ago, specialized in the sector Commerce de détail d'articles médicaux et orthopédiques en magasin spécialisé. Based in VILLENEUVE-D'ASCQ (59650), this company of category GE shows in 2024 a revenue of 2.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-08-08

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Synthèse

Santé financière : Saine

Aucun signal de fragilité majeur : rentabilité positive et structure financière équilibrée.

In summary, MSANTE posts positive profitability over the latest financial year. Its financial structure is fragile, with debt above sector norms — a point to monitor.

Financial history - MSANTE (SIREN 795379619)
Indicator 2024 2023 2022 2020 2019 2018 2017
Revenue 2 338 036 € 2 165 730 € 2 576 692 € N/C N/C N/C N/C
Net income 76 492 € -214 430 € -210 999 € 46 535 € 161 324 € 14 545 € 0 €
EBITDA 201 105 € -165 108 € -188 124 € N/C N/C N/C N/C
Net margin 3.3% -9.9% -8.2% N/C N/C N/C N/C

Revenue and income statement

In 2024, MSANTE achieves revenue of 2.3 M€. Activity remains stable over the period (CAGR: -4.7%). Vs 2023: +8%. After deducting consumption (566 k€), gross margin stands at 1.8 M€, i.e. a rate of 76%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 201 k€, representing 8.6% of revenue. Positive scissor effect: EBITDA margin improves by +16.2 pts, sign of improved operational efficiency. This ratio is more favorable than the sector median (8.2%). Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 76 k€, i.e. 3.3% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

2 338 036 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

1 771 702 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

201 105 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

79 804 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

76 492 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

8.6%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1090%. This ratio is less favorable than the sector median (31.9%) and warrants attention. Financial autonomy (= Equity / Total assets x 100) reaches 5%. This ratio is less favorable than the sector median (35.4%) and warrants attention. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.4 years of cash flow to repay all financial debt. This ratio is slightly less favorable than the sector median (0.6 years). Cash flow represents 8.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This ratio is more favorable than the sector median (5.9%).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1090.15%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

4.54%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

8.17%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

1.41

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

40.0%

Solvency indicators evolution
MSANTE

Sector positioning

Debt ratio
1090.15% 2024
Q1: 5.16%
Med: 31.89%
Q3: 104.46%
Watch +20 pts over 2 years

In 2024, the debt ratio of MSANTE (1090.2%) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
4.54% 2024
Q1: 16.07%
Med: 35.43%
Q3: 57.27%
Watch -22 pts over 2 years

In 2024, the financial autonomy of MSANTE (4.5%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
1.41 years 2024
Q1: 0.0 years
Med: 0.64 years
Q3: 2.1 years
Average

In 2024, the repayment capacity of MSANTE (1.41) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1.28. This ratio is less favorable than the sector median (2.0) and warrants attention. The interest coverage ratio (= EBIT / Interest expenses) is 5.0x. Compared with its sector, this ratio places the company among the best positioned (sector median: 0.8x).

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1.28

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

5.04

Liquidity indicators evolution
MSANTE

Sector positioning

Liquidity ratio
1.28 2024
Q1: 1.38
Med: 1.99
Q3: 3.21
Watch +5 pts over 3 years

In 2024, the liquidity ratio of MSANTE (1.28) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
5.04x 2024
Q1: 0.0x
Med: 0.85x
Q3: 4.59x
Excellent +51 pts over 3 years

In 2024, the interest coverage of MSANTE (5.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 16 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 32 days. Favorable situation: supplier credit is longer than customer credit by 16 days. Inventory turnover is 13 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 28 days of revenue, i.e. 181 k€ to permanently finance.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

181 011 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

16 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

32 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

13 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

28 j

WCR and payment terms evolution
MSANTE

Positioning of MSANTE in its sector

Comparison with sector Commerce de détail d'articles médicaux et orthopédiques en magasin spécialisé

Valuation estimate

Based on 161 transactions of similar company sales (all years), the value of MSANTE is estimated at 547 425 € (range 321 031€ - 1 280 500€). With an EBITDA of 201 105€, the sector multiple of 2.7x is applied. The price/revenue ratio is 0.32x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
161 transactions
321k€ 547k€ 1280k€
547 425 € Range: 321 031€ - 1 280 500€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
201 105 € × 2.7x
Estimation 544 236 €
311 234€ - 1 542 146€
Revenue Multiple 30%
2 338 036 € × 0.32x
Estimation 751 943 €
490 595€ - 1 377 425€
Net Income Multiple 20%
76 492 € × 3.3x
Estimation 248 623 €
91 179€ - 480 999€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 161 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail d'articles médicaux et orthopédiques en magasin spécialisé)

Compare MSANTE with other companies in the same sector:

Top companies in Commerce de détail d'articles médicaux et orthopédiques en magasin spécialisé

Largest companies by revenue in the sector Commerce de détail d'articles médicaux et orthopédiques en magasin spécialisé:

Top companies in Nord

Largest companies by revenue in the department Nord:

Frequently asked questions about MSANTE

What is the revenue of MSANTE ?

The revenue of MSANTE in 2024 is 2.3 M€.

Is MSANTE profitable?

Yes, MSANTE generated a net profit of 76 k€ in 2024.

Where is the headquarters of MSANTE ?

The headquarters of MSANTE is located in VILLENEUVE-D'ASCQ (59650), in the department Nord.

Where to find the tax return of MSANTE ?

The tax return of MSANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MSANTE operate?

MSANTE operates in the sector Commerce de détail d'articles médicaux et orthopédiques en magasin spécialisé (NAF code 47.74Z). See the 'Sector positioning' section above to compare the company with its competitors.